Cargando…
An analogue of a kinase inhibitor exhibits subjective characteristics that contribute to its inhibitory activities as a potential anti-cancer candidate: insights through computational biomolecular modelling of UM-164 binding with lyn protein
The recent emergence of lyn kinase as a driver of aggressive behaviour in triple-negative breast cancer (TNBC) remains a major concern posing a burden for people living with breast cancer and drug development. The binding of UM-164 to lyn protein has been noted to impact the conformational dynamics...
Autores principales: | Ndagi, Umar, Abdullahi, Maryam, Hamza, Asmau N., Soliman, Mahmoud E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047091/ https://www.ncbi.nlm.nih.gov/pubmed/35492550 http://dx.doi.org/10.1039/c9ra07204g |
Ejemplares similares
-
Impact of Drug Repurposing on SARS-Cov-2 Main Protease
por: Ndagi, Umar, et al.
Publicado: (2023) -
Antibiotic resistance: bioinformatics-based understanding as a functional strategy for drug design
por: Ndagi, Umar, et al.
Publicado: (2020) -
Metal complexes in cancer therapy – an update from drug design perspective
por: Ndagi, Umar, et al.
Publicado: (2017) -
UM-164, a Dual Inhibitor of c-Src and p38 MAPK, Suppresses Proliferation of Glioma by Reducing YAP Activity
por: Xu, Huizhe, et al.
Publicado: (2022) -
Essential Role of Lyn in Fibrosis
por: Pham, Hung, et al.
Publicado: (2016)